Active, Not Recruiting
Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer
NCT02893917
- Conditions
- Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation, Castration-Resistant Prostate Carcinoma, Genital Diseases, +13 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- UC San Diego Medical Center - Hillcrest San Diego, California, United States
- Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States